Complete

Like molecular clockwork – how biological timers control the immune system

Cancer types:

Lymphoma

Project period:

Research institute:

The Walter and Eliza Hall Institute of Medical Research

Award amount:

£217,541

Location:

Australia

Researcher Professor Philip Hodgkin

Professor Philip Hodgkin and his team aim to get a better grip on how the immune system works when activated and how this knowledge can help to better understand the development of certain blood cancers.  

Meet the scientist

Philip Hodgkin is a professor and division head at the Walter and Eliza Hall Institute of Medical Research in Victoria, Australia. His lab use computational models to understand how cells communicate and work together as part of the immune system. 

The science

Professor Philip Hodgkin, based in Australia, is using funding from Worldwide Cancer Research to work out the molecular "clockwork" behind biological timers that control how the immune system responds once it is activated. His team are particularly interested in looking at genes that keep these timers ticking that are also involved in lymphoma. They hope that their approach will reveal more about how the normal immune response works so that they can identify what is going wrong when lymphoma develops. 

Related projects

Active United Kingdom

Lymphoma

Can we find a way to switch anti-cancer genes back on?

This project will explore a cancer mutation which could be key to finding  new way stop cancer progressing, opening the door to future new treatments.

Researcher: Professor Richard Jenner

A new way to switch anti-cancer genes back on

Active Switzerland

Lymphoma

How do healthy blood cells help drive lymphoma development?

Understanding how healthy cells support the survival and growth of lymphoma will ultimately lead to the development of essential new treatments.

Researcher: Professor Davide Rossi

How genetic mutations in healthy blood cells can help drive lymphoma development

Active Italy

Lymphoma

How do aggressive lymphomas grow and can we stop them?

Lymphomas can sometimes come back even after successful treatment so this project is exploring a possible new way to target this disease and improve patient outcomes. 

Researcher: Professor Bruno Amati

Seeking a possible new target for lymphoma treatment
Share this page